ZA200903873B - Sphingosine-1-phosphate receptor agonist and antagonist compounds - Google Patents
Sphingosine-1-phosphate receptor agonist and antagonist compoundsInfo
- Publication number
- ZA200903873B ZA200903873B ZA200903873A ZA200903873A ZA200903873B ZA 200903873 B ZA200903873 B ZA 200903873B ZA 200903873 A ZA200903873 A ZA 200903873A ZA 200903873 A ZA200903873 A ZA 200903873A ZA 200903873 B ZA200903873 B ZA 200903873B
- Authority
- ZA
- South Africa
- Prior art keywords
- sphingosine
- receptor agonist
- antagonist compounds
- phosphate receptor
- phosphate
- Prior art date
Links
- 229940121846 Sphingosine 1-phosphate receptor agonist Drugs 0.000 title 1
- 229940122286 Sphingosine 1-phosphate receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87628806P | 2006-12-21 | 2006-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200903873B true ZA200903873B (en) | 2010-10-27 |
Family
ID=41484159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200903873A ZA200903873B (en) | 2006-12-21 | 2009-06-03 | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101610674A (en) |
| ZA (1) | ZA200903873B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012041359A1 (en) * | 2010-10-01 | 2012-04-05 | Synthon B.V. | Process for making fingolimod |
| UY35338A (en) * | 2013-02-21 | 2014-08-29 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | BICYCLIC COMPOUNDS MODULATING THE ACTIVITY OF S1P1 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US9306212B2 (en) * | 2013-07-19 | 2016-04-05 | Samsung Sdi Co., Ltd. | Positive active material for rechargeable lithium battery, and positive electrode and rechargeable lithium battery including the same |
| AR101591A1 (en) * | 2014-08-20 | 2016-12-28 | Bristol Myers Squibb Co | REPLACED BICYCLIC COMPOUNDS |
-
2007
- 2007-12-21 CN CNA2007800514855A patent/CN101610674A/en active Pending
-
2009
- 2009-06-03 ZA ZA200903873A patent/ZA200903873B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101610674A (en) | 2009-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2120575A4 (en) | Sphingosine-1 -phosphate receptor agonist and antagonist compounds | |
| IL198249A0 (en) | Compositions comprising an opioid agonist and an opioid antagonist | |
| IL239402A0 (en) | Kinase antagonists | |
| EP2058304A4 (en) | P2x4 receptor antagonist | |
| EP2034832A4 (en) | Il-8 receptor antagonist | |
| EP2173174A4 (en) | Farnesoid x receptor agonists | |
| EP2170072A4 (en) | Farnesoid x receptor agonists | |
| IL198650A0 (en) | Progesterone receptor antagonists | |
| IL193279A0 (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| ZA201107743B (en) | Diamide compounds having muscarinic receptor antagonist and b2 adrenergic receptor agonist activity | |
| IL195071A0 (en) | Cannabinoid receptor antagonists/inverse agonists | |
| ZA200808817B (en) | Dialkylphenyl compounds having ß2 adrenergic receptor agonist and muscarinic receptor antagonist activity | |
| SI2018165T1 (en) | Fgf-peceptor agonist dimeric compounds | |
| IL195807A0 (en) | Cgrp receptor antagonists | |
| EP2191830A4 (en) | Solid preparation comprising npyy5 receptor antagonist | |
| EP2075252A4 (en) | Nk1 receptor antagonist composition | |
| IL205949A0 (en) | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | |
| ZA200903873B (en) | Sphingosine-1-phosphate receptor agonist and antagonist compounds | |
| ZA200903523B (en) | Poly-TLR antagonist | |
| GB0525029D0 (en) | Receptor Antagonist | |
| ZA200806992B (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| HK1137942A (en) | Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist | |
| HK1131135A (en) | Novel compounds as antagonists or inverse agonists at opioid receptors | |
| GB0724656D0 (en) | Prolactin agonist | |
| HK1155164A (en) | Sphingosine-1-phosphate receptor antagonists |